Triquetra Health Launches Folura™ -- One Studied Saw Palmetto Active That Works at the Root, Not Just the Strand

Folura Delivers Serevelle™ Saw Palmetto at the Exact 160 mg Dose Used in Randomized Trials — Now Available on Amazon for Men and Women

AUSTIN, Texas, Oct. 14, 2026 /PRNewswire/ -- Triquetra Health, a supplement company built on single-active formulation and full-label transparency, today announced the launch of Folura™, a once-daily hair softgel built on one studied active. Folura is designed to work at the root, not just the strand — supporting the hair follicle, where thinning starts, rather than supplying nutrients to the hair already on the head. Formulated for men and women experiencing hair thinning, Folura is available now on Amazon and at triquetrahealth.com.

Most hair supplements just feed the hair you already have — biotin, collagen, and long vitamin lists aimed at the visible strand. For most adults who are thinning, that is the wrong layer. Thinning begins deeper, at the follicle, where a shift in hormonal activity gradually shortens the growth cycle and, over time, produces finer hair that sheds sooner. The result is a category that nourishes existing hair while leaving the root of thinning largely unaddressed.

Folura takes the opposite approach with one studied active at the exact researched dose. It is built on Serevelle™, a concentrated saw palmetto (Serenoa repens) extract standardized to its bioactive free fatty acids and dosed at 160 mg per softgel — delivering 105 mg of the ActiLipid4Hair™ complex, the exact amount used in the published trials. Serevelle supports the follicle at the root: it supports healthy DHT balance at the follicle while also supporting the active growth phase of the hair cycle. Both ingredients are disclosed on the label — no proprietary blend. The product is available at amazon.com/dp/B0HGNWDQM6.

Serevelle is clinically studied for hair — in men and women. In a six-month randomized, double-blind, placebo-controlled trial, participants taking the active gained roughly 25 more hairs in total hair density over six months, while the placebo group's counts declined by about 12 — 306% greater total hair density versus placebo (p<0.001; Ablon 2026, Journal of Cosmetic Dermatology). The trial enrolled men and women equally, benefits continued to build through month six (roughly 40% larger at day 180 than at day 90), and no treatment-related adverse events were reported. Many people notice less in the brush within the first weeks, with fuller-looking hair building over three to six months. Folura contains Serevelle at that same 160 mg dose.

"For years, the hair-supplement aisle has asked people to feed the hair they already have and hope," said Sean Gill, Founder of Triquetra Health.
"We built Folura the opposite way — one studied active at the exact researched dose, working at the root, not just the strand. Serevelle was studied for hair in men and women, and we put it in the bottle at the amount the researchers actually used. This is what supporting fuller, thicker-looking hair at the source should look like — and the Supplement Facts panel is the pitch."

Each Folura softgel provides 160 mg Serevelle™ saw palmetto extract alongside 232 mg of cold-pressed pumpkin seed oil, which serves as a companion botanical and the softgel's natural oil base, plus a mixed-tocopherol and rosemary antioxidant system that keeps the oils stable across shelf life. Folura is manufactured in a GMP-certified facility on a USP-verified Serevelle extract platform, with third-party testing for purity, potency, and heavy metals. Full product details are available at triquetrahealth.com/products/folura.

Folura™ is available now on Amazon at https://www.amazon.com/dp/ B0HGNWDQM6 and at triquetrahealth.com. Taken as one softgel a day with a meal, it offers a focused, fully disclosed approach for men and women who want to support fuller, thicker-looking hair at the root.

About Triquetra Health

Triquetra Health develops evidence-based nutritional supplements for consumers who demand clinical validation and full-label transparency. The company specializes in focused, single-active formulations built on studied ingredients at their researched doses — rather than multi-ingredient blends at undisclosed amounts. All Triquetra products are manufactured in GMP-certified facilities with third-party testing for purity, potency, and heavy metals. For more information, visit triquetrahealth.com.

Scope of evidence: Based on one six-month randomized, placebo-controlled trial of the Serevelle™ extract (N=60; Ablon 2025 & 2026, Journal of Cosmetic Dermatology), supplier-sponsored, single principal investigator, published in two stages. Folura™ was not itself trialed; figures reflect the Serevelle™ ingredient at the 160 mg dose contained in the product. Individual results may vary.

Media Contact: 
LeAnna Doughty
Director of Communications
[email protected]
+ (844) 272-6337

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

SOURCE Triquetra Health LLC